BPL employs advanced plasma fractionation techniques that first separate coagulation factors, then immunoglobulins and finally albumin.
Stringent safety and quality standards, alongside state-of-the-art screening and viral removal/inactivation systems, ensure that all BPL blood products can be used with confidence.
BPL has sufficient manufacturing capacity and raw material to ensure a long term commitment to continuity of supply for patients requiring therapy.
Products that can be made from our plasma
